Impact of diabetes on COVID-19 and other infection: Report from the 22nd Hong Kong Diabetes and Cardiovascular Risk Factors-East Meets West Symposium
- PMID: 33615546
- PMCID: PMC7995062
- DOI: 10.1111/dme.14547
Impact of diabetes on COVID-19 and other infection: Report from the 22nd Hong Kong Diabetes and Cardiovascular Risk Factors-East Meets West Symposium
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has posed enormous challenges to healthcare systems worldwide. The negative impact of COVID-19 is widespread and includes not only people who contracted the disease but also those with chronic morbidities such as diabetes whose care is compromised due to diversion of medical resources. People with diabetes are generally more susceptible to infection as a result of altered immunity. People with diabetes have a worse prognosis from COVID-19 and there is evidence to suggest that severe acute respiratory syndrome coronavirus 2 may directly affect pancreatic function precipitating hyperglycaemic crises. In the United Kingdom, one of the most heavily affected countries, guidelines are in place to unify the management of people with diabetes hospitalized for COVID-19. Diabetes services are re-organized to ensure that medical care of people with diabetes is maintained despite resource and other practical constraints. Public health measures including social distancing, hand hygiene and the use of face masks are crucial in containing community transmission of the virus. Hong Kong, one of the most densely populated city in the world, is particularly vulnerable and has in place a stringent containment policy and aggressive contact tracing to ensure public safety during this pandemic.
Keywords: COVID-19; diabetes; infection.
© 2021 Diabetes UK.
Conflict of interest statement
A.O.Y.L has received research grants from Amgen, Bayer, Boehringer Ingelheim, Lee's Pharmaceutical, MSD, Roche and Sanofi for conducting clinical trials or investigator‐initiated trials. A.O.Y.L has received travel grants and/or speaker honoraria from Astra Zeneca, Boehringer Ingelheim, Eli‐Lilly, MSD, Novo Nordisk and Sanofi. The funders have no role in manuscript preparation or publication decision. S.S.S.N has no conflict of interest to declare. R.I.G.H. has received honoraria for speaker engagement, conference attendance or advisory boards from AstraZeneca, Boehringer‐Ingelheim, European Association for the Study of Diabetes, Eli Lilly, Janssen, Menarini, Mylan, Novo Nordisk, Omniamed, Otsuka.
Figures
Similar articles
-
Behavioural insights and attitudes on community masking during the initial spread of COVID-19 in Hong Kong.Hong Kong Med J. 2021 Apr;27(2):106-112. doi: 10.12809/hkmj209015. Epub 2021 Mar 25. Hong Kong Med J. 2021. PMID: 33762440
-
The 5% of the Population at High Risk for Severe COVID-19 Infection Is Identifiable and Needs to Be Taken Into Account When Reopening the Economy.J Psychiatr Pract. 2020 May;26(3):219-227. doi: 10.1097/PRA.0000000000000475. J Psychiatr Pract. 2020. PMID: 32421292 Free PMC article.
-
Impact of Wearing Masks, Hand Hygiene, and Social Distancing on Influenza, Enterovirus, and All-Cause Pneumonia During the Coronavirus Pandemic: Retrospective National Epidemiological Surveillance Study.J Med Internet Res. 2020 Aug 20;22(8):e21257. doi: 10.2196/21257. J Med Internet Res. 2020. PMID: 32750008 Free PMC article.
-
Infections and diabetes: Risks and mitigation with reference to India.Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1889-1894. doi: 10.1016/j.dsx.2020.09.022. Epub 2020 Sep 22. Diabetes Metab Syndr. 2020. PMID: 33002780 Free PMC article. Review.
-
Community interventions in Low-And Middle-Income Countries to inform COVID-19 control implementation decisions in Kenya: A rapid systematic review.PLoS One. 2020 Dec 8;15(12):e0242403. doi: 10.1371/journal.pone.0242403. eCollection 2020. PLoS One. 2020. PMID: 33290402 Free PMC article.
Cited by
-
Health-Related Quality of Life of Moroccan COVID-19 Survivors: A Case-Control Study.Int J Environ Res Public Health. 2022 Jul 20;19(14):8804. doi: 10.3390/ijerph19148804. Int J Environ Res Public Health. 2022. PMID: 35886656 Free PMC article.
-
Effectiveness of SARS-CoV-2 primary vaccines and boosters in patients with type 2 diabetes mellitus in Hungary (HUN-VE 4 Study).BMJ Open Diabetes Res Care. 2024 Jan 24;12(1):e003777. doi: 10.1136/bmjdrc-2023-003777. BMJ Open Diabetes Res Care. 2024. PMID: 38267204 Free PMC article.
-
Pulmonary mucormycosis in the aftermath of critical COVID-19 in an immunocompromised patient: Mind the diagnostic gap.J Mycol Med. 2022 Mar;32(1):101228. doi: 10.1016/j.mycmed.2021.101228. Epub 2021 Nov 18. J Mycol Med. 2022. PMID: 34826672 Free PMC article.
-
Association Between Previous Stroke and Severe COVID-19: A Retrospective Cohort Study and an Overall Review of Meta-Analysis.Front Neurol. 2022 Jul 12;13:922936. doi: 10.3389/fneur.2022.922936. eCollection 2022. Front Neurol. 2022. PMID: 35911884 Free PMC article.
-
The association of care burden with motivation of vaccine acceptance among caregivers of stroke patients during the COVID-19 pandemic: mediating roles of problematic social media use, worry, and fear.BMC Psychol. 2023 May 15;11(1):157. doi: 10.1186/s40359-023-01186-3. BMC Psychol. 2023. PMID: 37183253 Free PMC article.
References
-
- World Health Organization . https://covid19.who.int. Accessed January 22, 2021.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical